186 related articles for article (PubMed ID: 10922199)
1. Metastatic melanoma death rates by anatomic site after proton beam irradiation for uveal melanoma.
Li W; Gragoudas ES; Egan KM
Arch Ophthalmol; 2000 Aug; 118(8):1066-70. PubMed ID: 10922199
[TBL] [Abstract][Full Text] [Related]
2. Tumor basal area and metastatic death after proton beam irradiation for choroidal melanoma.
Li W; Gragoudas ES; Egan KM
Arch Ophthalmol; 2003 Jan; 121(1):68-72. PubMed ID: 12523887
[TBL] [Abstract][Full Text] [Related]
3. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma.
Gragoudas ES; Lane AM; Munzenrider J; Egan KM; Li W
Trans Am Ophthalmol Soc; 2002; 100():43-8; discussion 48-9. PubMed ID: 12545676
[TBL] [Abstract][Full Text] [Related]
4. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement.
Gündüz K; Shields CL; Shields JA; Cater J; Freire JE; Brady LW
Arch Ophthalmol; 1999 Feb; 117(2):170-7. PubMed ID: 10037560
[TBL] [Abstract][Full Text] [Related]
5. Survival after proton-beam irradiation of uveal melanomas.
Kodjikian L; Roy P; Rouberol F; Garweg JG; Chauvel P; Manon L; Jean-Louis B; Little RE; Sasco AJ; Grange JD
Am J Ophthalmol; 2004 Jun; 137(6):1002-10. PubMed ID: 15183783
[TBL] [Abstract][Full Text] [Related]
6. Relative survival rates after alternative therapies for uveal melanoma.
Seddon JM; Gragoudas ES; Egan KM; Glynn RJ; Howard S; Fante RG; Albert DM
Ophthalmology; 1990 Jun; 97(6):769-77. PubMed ID: 2374681
[TBL] [Abstract][Full Text] [Related]
7. Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy.
Lane AM; Kim IK; Gragoudas ES
JAMA Ophthalmol; 2015 Jul; 133(7):792-6. PubMed ID: 25905597
[TBL] [Abstract][Full Text] [Related]
8. Survival implications of enucleation after definitive radiotherapy for choroidal melanoma: an example of regression on time-dependent covariates.
Egan KM; Ryan LM; Gragoudas ES
Arch Ophthalmol; 1998 Mar; 116(3):366-70. PubMed ID: 9514491
[TBL] [Abstract][Full Text] [Related]
9. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension.
Gündüz K; Shields CL; Shields JA; Cater J; Brady L
Am J Ophthalmol; 2000 Jul; 130(1):97-102. PubMed ID: 11004266
[TBL] [Abstract][Full Text] [Related]
10. A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma.
Kroll S; Char DH; Quivey J; Castro J
Ophthalmology; 1998 Nov; 105(11):2035-45. PubMed ID: 9818602
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy: indications and comparison of local recurrence rates].
Desjardins L; Lumbroso L; Levy C; Mazal A; Delacroix S; Rosenwald JC; Dendale R; Plancher C; Asselain B
J Fr Ophtalmol; 2003 Mar; 26(3):269-76. PubMed ID: 12746603
[TBL] [Abstract][Full Text] [Related]
12. Posterior uveal melanoma in young patients treated with proton beam therapy.
Vavvas D; Kim I; Lane AM; Chaglassian A; Mukai S; Gragoudas E
Retina; 2010 Sep; 30(8):1267-71. PubMed ID: 20224468
[TBL] [Abstract][Full Text] [Related]
13. Metastasis from uveal melanoma after proton beam irradiation.
Gragoudas ES; Seddon JM; Egan KM; Glynn RJ; Goitein M; Munzenrider J; Verhey L; Urie M; Koehler A
Ophthalmology; 1988 Jul; 95(7):992-9. PubMed ID: 2845324
[TBL] [Abstract][Full Text] [Related]
14. [Ciliary body melanomas. Survival and prognostic aspects after brachytherapy or proton therapy].
Gambrelle J; Kodjikian L; Rouberol F; Donate D; Duquesne N; Jean-Louis B; Chauvel P; Gérard JP; Romestaing P; Grange JD
J Fr Ophtalmol; 2004 Jan; 27(1):40-7. PubMed ID: 14968076
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for metastasis following proton beam irradiation of uveal melanomas.
Gragoudas ES; Seddon JM; Egan KM; Polivogianis L; Hsieh CC; Goitein M; Verhey L; Munzenrider J; Austin-Seymour M; Urie M
Ophthalmology; 1986 May; 93(5):675-80. PubMed ID: 3014416
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
17. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO).
Dendale R; Lumbroso-Le Rouic L; Noel G; Feuvret L; Levy C; Delacroix S; Meyer A; Nauraye C; Mazal A; Mammar H; Garcia P; D'Hermies F; Frau E; Plancher C; Asselain B; Schlienger P; Mazeron JJ; Desjardins L
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):780-7. PubMed ID: 16647221
[TBL] [Abstract][Full Text] [Related]
18. Plaque radiotherapy for choroidal and ciliochoroidal melanomas with limited nodular extrascleral extension.
Augsburger JJ; Schneider S; Narayana A; Breneman JC; Aron BS; Barrett WL; Trichopoulos N
Can J Ophthalmol; 2004 Jun; 39(4):380-7. PubMed ID: 15327103
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
Isager P; Ehlers N; Overgaard J
Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
[TBL] [Abstract][Full Text] [Related]
20. Long-term Outcomes After Proton Beam Irradiation in Patients With Large Choroidal Melanomas.
Papakostas TD; Lane AM; Morrison M; Gragoudas ES; Kim IK
JAMA Ophthalmol; 2017 Nov; 135(11):1191-1196. PubMed ID: 29049518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
